BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 10412329)

  • 21. Cardiac sympathetic activity as measured by myocardial 123-I-metaiodobenzylguanidine uptake and heart rate variability in idiopathic dilated cardiomyopathy.
    Lotze U; Kober A; Kaepplinger S; Neubauer S; Gottschild D; Figulla HR
    Am J Cardiol; 1999 Jun; 83(11):1548-51. PubMed ID: 10363869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative scintigraphic analysis of 123I-MIBG by polar map in patients with dilated cardiomyopathy.
    Yamazaki J; Muto H; Ishiguro S; Okamoto K; Hosoi H; Nakano H; Morishita T
    Nucl Med Commun; 1997 Mar; 18(3):219-29. PubMed ID: 9106775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgical ventricular restoration in patients with ischemic dilated cardiomyopathy: evaluation of systolic and diastolic ventricular function, wall stress, dyssynchrony, and mechanical efficiency by pressure-volume loops.
    Tulner SA; Steendijk P; Klautz RJ; Bax JJ; Schalij MJ; van der Wall EE; Dion RA
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):610-20. PubMed ID: 16935117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation of iodine-123 metaiodobenzylguanidine myocardial scintigraphy to endomyocardial biopsy findings in patients with dilated cardiomyopathy.
    Murata K; Kusachi S; Murakami T; Nogami K; Murakami M; Hirohata S; Tominaga Y; Komatsubara I; Tsuji T
    Clin Cardiol; 1997 Jan; 20(1):61-6. PubMed ID: 8994740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in cardiac sympathetic nerve innervation and activity in pathophysiologic transition from typical to end-stage hypertrophic cardiomyopathy.
    Terai H; Shimizu M; Ino H; Yamaguchi M; Uchiyama K; Oe K; Nakajima K; Taki J; Kawano M; Mabuchi H
    J Nucl Med; 2003 Oct; 44(10):1612-7. PubMed ID: 14530475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term prognostic stratification by a combination of (123)I-metaiodobenzylguanidine scintigraphy and ejection fraction in dilated cardiomyopathy.
    Momose M; Okayama D; Nagamatsu H; Kondo C; Hagiwara N; Sakai S
    Ann Nucl Med; 2011 Jul; 25(6):419-24. PubMed ID: 21461599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disproportionate shortening of left ventricular diastolic duration in patients with dilated cardiomyopathy].
    Plehn G; Vormbrock J; Zühlke C; Christ M; Perings C; Perings S; Trappe HJ; Meissner A
    Med Klin (Munich); 2007 Sep; 102(9):707-13. PubMed ID: 17879008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of iodine-123 metaiodobenzylguanidine uptake associated with left ventricular functional recovery in a patient with dilated cardiomyopathy. Endomyocardial histological findings before and after the improvement of uptake.
    Ueda T; Kusachi S; Yamaji H; Morishita N; Mima T; Imai M
    Jpn Heart J; 1997 Jan; 38(1):145-50. PubMed ID: 9186291
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of left ventricular diastolic function using Doppler echocardiography].
    Vlahović A; Popović AD
    Med Pregl; 1999; 52(1-2):13-8. PubMed ID: 10352498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulsed Doppler echocardiographic study of left ventricular diastolic function in patients with idiopathic dilated cardiomyopathy.
    Bahl VK; Chandra S; Boro AK; Goswami KC; Agarwal R; Basumatary G; Wasir HS
    J Assoc Physicians India; 1998 Mar; 46(3):257-60. PubMed ID: 11273341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial clearance of I-123 metaiodobenzylguanidine in dilated cardiomyopathy.
    Yamanari H; Sakamoto T; Takenaka S; Saito H; Koyama S; Ohe T
    Ann Nucl Med; 1997 Nov; 11(4):325-9. PubMed ID: 9460525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiodarone improves cardiac sympathetic nerve function to hold norepinephrine in the heart, prevents left ventricular remodeling, and improves cardiac function in rat dilated cardiomyopathy.
    Tachikawa H; Kodama M; Watanabe K; Takahashi T; Ma M; Kashimura T; Ito M; Hirono S; Okura Y; Kato K; Hanawa H; Aizawa Y
    Circulation; 2005 Feb; 111(7):894-9. PubMed ID: 15710769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Serial change of 123I-metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy].
    Yamakado K; Takeda K; Kitano T; Nakagawa T; Futagami Y; Konishi T; Hamada M; Nakano T; Ichihara T
    Kaku Igaku; 1990 Jul; 27(7):703-8. PubMed ID: 2232338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. I-123-MIBG cardiac uptake imaging, in familial dilated cardiomyopathy.
    Martins E; Faria T; Silva-Cardoso J; Oliveira A; Campelo M; Amorim S; Moura B; Rocha-Gonçalves F; Pereira JG; Maciel MJ
    Rev Port Cardiol; 2009 Jan; 28(1):29-36. PubMed ID: 19388491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Left ventricular longitudinal rotation changes in patients with dilated cardiomyopathy detected by two-dimensional speckle tracking imaging].
    Huang J; Ni XD; Hu YP; Song ZW; Yang WY; Xu R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):920-4. PubMed ID: 22321276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Left ventricular diastolic reserve during acute pressure loading in hypertrophic cardiomyopathy and dilated cardiomyopathy].
    Yokote Y; Okamoto M; Sakura E; Shimamoto H; Amioka H; Yamagata T; Hashimoto M; Tsuchioka Y; Matsuura H; Kajiyama G
    J Cardiol; 1988 Dec; 18(4):1051-60. PubMed ID: 3267714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure.
    Mu X; Hasegawa S; Yoshioka J; Maruyama A; Maruyama K; Paul AK; Yamaguchi H; Morozumi T; Hashimoto K; Kusuoka H; Nishimura T
    Ann Nucl Med; 2001 Oct; 15(5):411-6. PubMed ID: 11758945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of performing 123I-metaiodobenzylguanidine myocardial scintigraphy at different times for the long-term prediction of cardiac events in patients with dilated cardiomyopathy.
    Nakanishi R; Fujimoto S; Utanohara Y; Takamura K; Inoue A; Yamashina S; Namiki A; Yamazaki J
    Nucl Med Commun; 2010 Jun; 31(6):488-94. PubMed ID: 20429093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Comparison of Quantitative T2 Mapping on Cardiovascular Magnetic Resonance Imaging with Metaiodobenzylguanidine Scintigraphy and Left Ventricular Functional Recovery in Dilated Cardiomyopathy: A Retrospective Pilot Study.
    Ito T; K Kono A; Takamine S; Shigeru M; Mori S; Takaya T; Fujiwara S; Nishii T; Shiotani H; Sugimura K; Hirata K
    Intern Med; 2015; 54(17):2121-8. PubMed ID: 26328635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.
    Suga K; Ogasawara N; Ariga M; Motoyama K; Hara A; Kume N; Matsunaga N
    Eur J Nucl Med; 2000 May; 27(5):574-82. PubMed ID: 10853814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.